UPSTREAM CONSULTING

Registrant on federal lobbying filings · filed 2025 to 2026

$525,000 Income reported

5 Clients represented

30 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (88278), not by name.

Clients 5

AMERICAN KRATOM ASSOCIATION $285,000 6 filings
MANAGEMENT & TRAINING CORPORATION $135,000 6 filings
RARE ACCESS ACTION PROJECT $90,000 6 filings
ZIONS THERAPEUTICS $15,000 6 filings
PRIMUS PHARMACEUTICAL $0 6 filings

Reported by year 2 years

2026 $185,000 10 filings
2025 $340,000 20 filings

Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

HOUSE OF REPRESENTATIVES 30
SENATE 30
Food & Drug Administration (FDA) 6
Health & Human Services, Dept of (HHS) 6
White House Office 6

Recent filings 30 total

Q2 report

ZIONS THERAPEUTICS

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 17, 2026

View → Q2 report

RARE ACCESS ACTION PROJECT

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $15,000 income · posted Jul 17, 2026

View → Q2 report

PRIMUS PHARMACEUTICAL

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · posted Jul 17, 2026

View → Q2 report

AMERICAN KRATOM ASSOCIATION

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $47,500 income · posted Jul 17, 2026

View → Q2 report

MANAGEMENT & TRAINING CORPORATION

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $22,500 income · posted Jul 17, 2026

View → Q1 report

ZIONS THERAPEUTICS

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted May 4, 2026

View → Q1 report

RARE ACCESS ACTION PROJECT

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $15,000 income · posted May 4, 2026

View → Q1 report

PRIMUS PHARMACEUTICAL

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted May 4, 2026

View → Q1 report

AMERICAN KRATOM ASSOCIATION

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $47,500 income · posted May 4, 2026

View → Q1 report

MANAGEMENT & TRAINING CORPORATION

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $22,500 income · posted May 4, 2026

View → Q4 report

ZIONS THERAPEUTICS

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · posted Jan 30, 2026

View → Q4 report

RARE ACCESS ACTION PROJECT

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $15,000 income · posted Jan 30, 2026

View → Q4 report

PRIMUS PHARMACEUTICAL

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · posted Jan 30, 2026

View → Q4 report

AMERICAN KRATOM ASSOCIATION

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $47,500 income · posted Jan 30, 2026

View → Q4 report

MANAGEMENT & TRAINING CORPORATION

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $22,500 income · posted Jan 30, 2026

View → Q3 report

ZIONS THERAPEUTICS

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · posted Oct 25, 2025

View → Q3 report

RARE ACCESS ACTION PROJECT

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $15,000 income · posted Oct 25, 2025

View → Q3 report

PRIMUS PHARMACEUTICAL

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · posted Oct 25, 2025

View → Q3 report

AMERICAN KRATOM ASSOCIATION

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $47,500 income · posted Oct 25, 2025

View → Q3 report

MANAGEMENT & TRAINING CORPORATION

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $22,500 income · posted Oct 25, 2025

View →

Showing the 20 most recent of 30 filings. Search the explorer for "UPSTREAM CONSULTING".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.